HUMACYTE INC. - COMMON STOCK
4.6100
24-一月-25 15:45:00
15 分钟延时
股票
+0.0200
+0.44%
今日范围
4.4900 - 4.7500
ISIN
N/A
来源
NASDAQ
-
19 7月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
07 7月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
29 6月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Humacyte Expands Board of Directors with Appointment of Diane Seimetz, Ph.D.
27 6月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
21 6月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
Humacyte Presents New Immunogenicity Data on Human Acellular Vessels™ (HAVs™)
08 6月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Humacyte to Present at the H.C. Wainwright Global Investment Conference
16 5月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Humacyte First Quarter 2022 Financial Results and Business Update
13 5月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
09 5月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
06 5月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Humacyte Expands Leadership Team with Appointment of Shamik Parikh, M.D., as Chief Medical Officer
05 4月 2022 07:00:03 条件 Nasdaq GlobeNewswire
-
Humacyte Announces Date of Annual Shareholder Meeting
04 4月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update
29 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire
-
21 3月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Humacyte to Present at Upcoming Investor Conferences in March
01 3月 2022 07:00:04 条件 Nasdaq GlobeNewswire
-
28 2月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
09 2月 2022 06:30:00 条件 Nasdaq GlobeNewswire
-
28 1月 2022 08:15:00 条件 Nasdaq GlobeNewswire